Veracyte (VCYT) Preferred Stock Liabilities (2012)

Veracyte's (VCYT) quarterly Preferred Stock Liabilities came in at $63.4 million in Q4 2012.

Veracyte (VCYT) Preferred Stock Liabilities (2012) Analysis & Trends

Veracyte has disclosed Preferred Stock Liabilities across 1 years of filings, most recently posting $63.4 million for Q4 2012.

Preferred Stock Liabilities for Q4 2012 came in at $63.4 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2012 was $63.4 million (changed N/A YoY), and the FY2012 annual result was $63.4 million, up 28.55% from the prior year.
Preferred Stock Liabilities came in at $63.4 million for Q4 2012 at Veracyte.
In the past five years, Preferred Stock Liabilities ranged from a high of $63.4 million in Q4 2012 to a low of $63.4 million in Q4 2012.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Stock Liabilities (Qtr)
1	Waters	30,529.42 Bn	30,528.96 Bn	1.11 Bn	-
2	Thermo Fisher Scientific	183.75 Bn	180.50 Bn	7.74 Bn	-
3	Danaher	133.13 Bn	127.43 Bn	3.59 Bn	-
4	Idexx Laboratories	46.14 Bn	45.94 Bn	722.74 Mn	-
5	Agilent Technologies	38.20 Bn	36.39 Bn	990.00 Mn	-
6	Natera	31.50 Bn	30.40 Bn	696.04 Mn	-
7	Iqvia Holdings	31.34 Bn	29.36 Bn	1.36 Bn	-
8	Illumina	24.51 Bn	23.36 Bn	721.00 Mn	-
9	Mettler Toledo International	23.53 Bn	23.47 Bn	555.82 Mn	-
10	Veracyte	3.91 Bn	3.65 Bn	101.16 Mn	-

Download Data

Date	Value
Dec 31, 2012	63.37 Mn